Background illustration for clinical trials search

High Blood Pressure Clinical Trials

Browse 1,116 High Blood Pressure clinical trials enrolling across the United States and Canada. 95 people applied to High Blood Pressure studies last month. Search by city or state to find one near you.

Filter
1

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Providence RI, Philadelphia PA, Cleveland OH,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase1, Recruiting

Home Exercise for Individuals With Neurodegenerative Disease

for
Neurodegenerative Diseases, Leukodystrophy, Ataxia, LBSL,
Location: Baltimore MD
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Sex: All

Age: 5 - 70+

Code: NCT05443906

Recruiting

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Richmond VA, Columbus OH, Minneapolis MN
Sponsor: Yazeed Sawalha

Sex: All

Age: 18+

Code: NCT06536049

Phase1, Phase2, Recruiting

A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

for
Diffuse Large B Cell Lymphoma (DLBCL),
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 65 - 70+

Code: NCT06765317

Phase2, Recruiting

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma,
Location: Los Angeles CA, Sacramento CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18 - 70

Code: NCT05256641

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

for
Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma,
Location: Boston MA
Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All

Age: 18+

Code: NCT06026319

Phase1, Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Boston MA, Providence RI, The Bronx NY, New York NY,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase1, Recruiting

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

for
B-Cell Non-Hodgkin Lymphoma-Recurrent,
Location: Columbus OH
Sponsor: Nathan Denlinger

Sex: All

Age: 18+

Code: NCT06209619

Phase1, Recruiting

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

for
Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer,
Location: Pittsburgh PA
Sponsor: Dan Zandberg

Sex: All

Age: 18+

Code: NCT04114136

Phase2, Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Valhalla NY, Chapel Hill NC, Jacksonville FL,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase1, Phase2, Recruiting

Emapalumab Prevention of CAR-T Cell Associated Toxicities

for
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma,
Location: Boston MA
Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All

Age: 18+

Code: NCT06550141

Phase2, Recruiting

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

for
Recurrent Acute Lymphoblastic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 15+

Code: NCT03136146

Phase2, Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

for
B-Cell Leukemia, Non-Hodgkin's Lymphoma,
Location: Ottawa, Toronto, Calgary, Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 1+

Code: NCT06208735

Phase1, Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

for
Small Cell Carcinoma of the Bladder,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06228066

Phase2, Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for
Non Hodgkin Lymphoma,
Location: Boston MA, New Haven CT, Durham NC, Chicago IL,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06116110

Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

for
Advanced Cancer, Advanced Solid Tumor, Melanoma, Metastasis,
Location: Providence RI, Lebanon NH, Houston TX, Aurora CO
Sponsor: 7 Hills Pharma, LLC

Sex: All

Age: 18+

Code: NCT06362369

Phase1, Phase2, Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for
Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma,
Location: Boston MA, New York NY, Chicago IL, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT02332668

Phase1, Phase2, Recruiting

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

for
Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05039801

Phase1, Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: New York NY, Fairfax VA, Sarasota FL, Detroit MI,
Sponsor: Accent Therapeutics

Sex: All

Age: 18+

Code: NCT06799065

Phase1, Recruiting

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT06249191

Phase1, Phase2, Recruiting